Discover
PRPO
Precipio, Inc.
25.25
1 x 21.50
1 x 29.09
bid
ask
+
0.32
1.28%
01:08 PM
timesize
| Ytd | 9.88% | |
| 1y | 123.45% |
22.76
day range
25.36
11.22
52 week range
33.63
| Open | 25.29 | Prev Close | 24.93 | Low | 22.76 | High | 25.36 | Mkt Cap | 45.13M |
| Vol | 5.61K | Avg Vol | 33.03K | EPS | -0.45 | P/E | N/A | Forward P/E | 13.34 |
| Beta | 1.42 | Short Ratio | 0.59 | Inst. Own | 8.79% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 25.60 | 200-d Avg | 23.79 | 1yr Est | 19.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-06 | 2024-09 | 0 | -0.42 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -0.83 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -1.46 | N/A | N/A |
| 2024-03-29 | 2023-12 | 0 | -0.41 | N/A | N/A |
| 2023-11-13 | 2023-09 | 0 | -1.04 | N/A | N/A |
| 2023-08-11 | 2023-06 | 0 | -1.8 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-10-14 | ANDREWS RONALD ASBURY | Director | 11.13K | Stock Award(Grant) |
| 2024-10-14 | COHEN DAVID SETH | Director | 47.56K | Stock Award(Grant) |
| 2024-10-14 | COSSMAN JEFFREY M.D. | Director | 12.31K | Stock Award(Grant) |
| 2023-01-02 | DANIELI ILAN | Chief Executive Officer | 57.05K | Purchase |
| 2023-10-26 | FISHER DOUGLAS CARL M.D. | Director | 5.57K | Stock Award(Grant) |
| 2024-04-14 | LAPORTE KATHLEEN D | Director | 10.07K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Blackrock Inc. | 28.91K | 150.39K | 1.95% |
| 2024-09-29 | Vanguard Group Inc | 17.65K | 91.78K | 1.19% |
| 2024-09-29 | Geode Capital Management, LLC | 14.46K | 75.20K | 0.98% |
| 2024-09-29 | Wells Fargo & Company | 550.00 | 2.86K | 0.04% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 611.00 | 3.18K | 0.04% |
| 2024-09-29 | Citigroup Inc. | 470.00 | 2.44K | 0.03% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 17.65K | 91.78K | 1.19% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 7.15K | 37.21K | 0.48% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 3.10K | 16.11K | 0.21% |
| 2024-10-30 | Fidelity Total Market Index Fund | 1.88K | 9.77K | 0.13% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.75K | 9.11K | 0.12% |
Split
| Split | Date |
|---|---|
| 1 : 20 | 2023-09-22 |
| 1 : 15 | 2019-04-29 |